Related Experiment Video
Updated: Aug 13, 2026
14:14
Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
Serum tumor markers. Part I: Clinical utility
1Clinical Science Assessment for Laboratory Corporation of America, Burlington, NC, USA.
MLO: Medical Laboratory Observer
|January 27, 2006
Summary
Current serum tumor markers, often glycoproteins, primarily aid in evaluating advanced cancer therapy effectiveness. However, their limited sensitivity and specificity restrict early cancer detection and recurrence monitoring, highlighting the need for improved diagnostic tools.
Area of Science:
- Oncology
- Biochemistry
- Clinical Diagnostics
Background:
- Serum tumor markers, predominantly glycoproteins, are routinely measured using immunoassay techniques.
- Current applications include evaluating therapy effectiveness in advanced cancer and monitoring for recurrence in "cured" patients.
Purpose of the Study:
- To review the utility and limitations of current serum tumor markers.
- To emphasize the need for more sensitive and specific markers for early cancer detection and improved patient outcomes.
Main Methods:
- Review of existing literature and clinical practices regarding serum tumor markers.
- Analysis of the diagnostic and prognostic capabilities of current tumor marker assays.
Main Results:
- Most current tumor markers lack sufficient sensitivity and specificity for early cancer detection.
- Monitoring "cured" patients for recurrence with existing markers has not significantly improved outcomes.
- Decisions based on tumor marker concentrations require integration with the overall clinical context.
Conclusions:
- Current serum tumor markers have limited utility in early cancer screening and recurrence detection.
- There is a critical need for developing novel tumor markers with enhanced sensitivity and specificity.
- Future research should focus on improving markers for early diagnosis, therapy monitoring, and recurrence surveillance.
Related Concept Videos
01:30Serum Laboratory Studies, Stool Test, Breath Test
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.